Creating scale in nutritional health requires more than just a pipeline of products, it demands smart capital and commercial innovation. Bill Weldon shares how Axiota has successfully leveraged private equity backing to merge platforms, secure FDA approval, expand geographically, and ultimately scale into a profitable business.

Breaking into the animal health vaccines market requires overcoming high regulatory barriers and providing speed in response to outbreaks and evolving variants. Hanjo Hennemann shares how VEROVACCiNES leveraged a recombinant platform to rapidly design, test, and scale vaccines utilising regulatory pathways for broader and faster market entry.